|
1
|
Dey N, De P and Leyland-Jones B:
PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell
signaling to clinical trials. Pharmacol Ther. 175:91–106. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Herranz M and Ruibal A: Optical imaging in
breast cancer diagnosis: The next evolution. J Oncol.
2012:8637472012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shah NR and Chen H: MicroRNAs in
pathogenesis of breast cancer: Implications in diagnosis and
treatment. World J Clin Oncol. 5:48–60. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miller RP, Tadagavadi RK, Ramesh G and
Reeves WB: Mechanisms of cisplatin nephrotoxicity. Toxins.
2:2490–2518. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shi S, Tan P, Yan B, Gao R, Zhao J, Wang
J, Guo J, Li N and Ma Z: ER stress and autophagy are involved in
the apoptosis induced by cisplatin in human lung cancer cells.
Oncol Rep. 35:2606–2614. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Czarnomysy R, Surażyński A, Popławska B,
Rysiak E, Pawłowska N, Czajkowska A, Bielawski K and Bielawska A:
Synergistic action of cisplatin and echistatin in MDA-MB-231 breast
cancer cells. Mol Cell Biochem. 427:13–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gewirtz DA: Cytoprotective and
nonprotective autophagy in cancer therapy. Autophagy. 9:1263–1265.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mah LY and Ryan KM: Autophagy and cancer.
Cold Spring Harb Perspect Biol. 4:a0088212012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liang DH, El-Zein R and Dave B: Autophagy
inhibition to increase radiosensitization in breast cancer. J Nucl
Med Radiat Ther. 6:2542015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aydinlik S, Erkisa M, Cevatemre B,
Sarimahmut M, Dere E, Ari F and Ulukaya E: Enhanced cytotoxic
activity of doxorubicin through the inhibition of autophagy in
triple negative breast cancer cell line. Biochim Biophys Acta.
1861:49–57. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wen J, Yeo S, Wang C, Chen S, Sun S, Haas
MA, Tu W, Jin F and Guan JL: Autophagy inhibition re-sensitizes
pulse stimulation-selected paclitaxel-resistant triple negative
breast cancer cells to chemotherapy-induced apoptosis. Breast
Cancer Res Treat. 149:619–629. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu L, Gu C, Zhong D, Shi L, Kong Y, Zhou Z
and Liu S: Induction of autophagy counteracts the anticancer effect
of cisplatin in human esophageal cancer cells with acquired drug
resistance. Cancer Lett. 355:34–45. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Basu S, Rajakaruna S, Reyes B, Van
Bockstaele E and Menko AS: Suppression of MAPK/JNK-MTORC1 signaling
leads to premature loss of organelles and nuclei by autophagy
during terminal differentiation of lens fiber cells. Autophagy.
10:1193–1211. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zeng Y, Yang X, Wang J, Fan J, Kong Q and
Yu X: Aristolochic acid I induced autophagy extenuates cell
apoptosis via ERK 1/2 pathway in renal tubular epithelial cells.
PLoS One. 7:e303122012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang X, Wang J, Dai J, Shao J, Ma J, Chen
C, Ma S, He Q, Luo P and Yang B: Autophagy protects against
dasatinib-induced hepatotoxicity via p38 signaling. Oncotarget.
6:6203–6217. 2015.PubMed/NCBI
|
|
16
|
Zhi X, Zhao D, Zhou Z, Liu R and Chen C:
YAP promotes breast cell proliferation and survival partially
through stabilizing the KLF5 transcription factor. Am J Pathol.
180:2452–2461. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sorrentino G, Ruggeri N, Zannini A,
Ingallina E, Bertolio R, Marotta C, Neri C, Cappuzzello E, Forcato
M, Rosato A, et al: Glucocorticoid receptor signalling activates
YAP in breast cancer. Nat Commun. 8:140732017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lamar JM, Stern P, Liu H, Schindler JW,
Jiang ZG and Hynes RO: The Hippo pathway target, YAP, promotes
metastasis through its TEAD-interaction domain. Proc Natl Acad Sci
USA. 109:E2441–E2450. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lefort S, Joffre C, Kieffer Y, Givel AM,
Bourachot B, Zago G, Bieche I, Dubois T, Meseure D, Vincent-Salomon
A, et al: Inhibition of autophagy as a new means of improving
chemotherapy efficiency in high-LC3B triple-negative breast
cancers. Autophagy. 10:2122–2142. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kwon Y, Vinayagam A, Sun X, Dephoure N,
Gygi SP, Hong P and Perrimon N: The Hippo signaling pathway
interactome. Science. 342:737–740. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Song Q, Mao B, Cheng J, Gao Y, Jiang K,
Chen J, Yuan Z and Meng S: YAP enhances autophagic flux to promote
breast cancer cell survival in response to nutrient deprivation.
PLoS One. 10:e01207902015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He J, Yu JJ, Xu Q, Wang L, Zheng JZ, Liu
LZ and Jiang BH: Downregulation of ATG14 by EGR1-MIR152 sensitizes
ovarian cancer cells to cisplatin-induced apoptosis by inhibiting
cyto-protective autophagy. Autophagy. 11:373–384. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sui X, Kong N, Ye L, Han W, Zhou J, Zhang
Q, He C and Pan H: p38 and JNK MAPK pathways control the balance of
apoptosis and autophagy in response to chemotherapeutic agents.
Cancer Lett. 344:174–179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Siddik ZH: Cisplatin: Mode of cytotoxic
action and molecular basis of resistance. Oncogene. 22:7265–7279.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Skolekova S, Matuskova M, Bohac M, Toro L,
Durinikova E, Tyciakova S, Demkova L, Gursky J and Kucerova L:
Cisplatin-induced mesenchymal stromal cells-mediated mechanism
contributing to decreased antitumor effect in breast cancer cells.
Cell Commun Signal. 14:42016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cataldo A, Cheung DG, Balsari A, Tagliabue
E, Coppola V, Iorio MV, Palmieri D and Croce CM: miR-302b enhances
breast cancer cell sensitivity to cisplatin by regulating E2F1 and
the cellular DNA damage response. Oncotarget. 7:786–797. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Carew JS, Nawrocki ST and Cleveland JL:
Modulating autophagy for therapeutic benefit. Autophagy. 3:464–467.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liang S, Peng X, Li X, Yang P, Xie L, Li
Y, Du C and Zhang G: Silencing of CXCR4 sensitizes triple-negative
breast cancer cells to cisplatin. Oncotarget. 6:1020–1030. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ambjørn M, Ejlerskov P, Liu Y, Lees M,
Jäättelä M and Issazadeh-Navikas S: IFNB1/interferon-β-induced
autophagy in MCF-7 breast cancer cells counteracts its proapoptotic
function. Autophagy. 9:287–302. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sui X, Chen R, Wang Z, Huang Z, Kong N,
Zhang M, Han W, Lou F, Yang J, Zhang Q, et al: Autophagy and
chemotherapy resistance: A promising therapeutic target for cancer
treatment. Cell Death Dis. 4:e8382013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wei Y, Pattingre S, Sinha S, Bassik M and
Levine B: JNK1-mediated phosphorylation of Bcl-2 regulates
starvation-induced autophagy. Mol Cell. 30:678–688. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li D, Hu J, Wang T, Zhang X, Liu L, Wang
H, Wu Y, Xu D and Wen F: Silymarin attenuates cigarette smoke
extract-induced inflammation via simultaneous inhibition of
autophagy and ERK/p38 MAPK pathway in human bronchial epithelial
cells. Sci Rep. 6:377512016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu YL, Lai F, Wilmott JS, Yan XG, Liu XY,
Luan Q, Guo ST, Jiang CC, Tseng HY, Scolyer RA, et al: Noxa
upregulation by oncogenic activation of MEK/ERK through CREB
promotes autophagy in human melanoma cells. Oncotarget.
5:11237–11251. 2014.PubMed/NCBI
|
|
35
|
Henson SM, Lanna A, Riddell NE, Franzese
O, Macaulay R, Griffiths SJ, Puleston DJ, Watson AS, Simon AK,
Tooze SA, et al: p38 signaling inhibits mTORC1-independent
autophagy in senescent human CD8+ T cells. J Clin
Invest. 124:4004–4016. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ciamporcero E, Shen H, Ramakrishnan S, Ku
Yu S, Chintala S, Shen L, Adelaiye R, Miles KM, Ullio C, Pizzimenti
S, et al: YAP activation protects urothelial cell carcinoma from
treatment-induced DNA damage. Oncogene. 35:1541–1553. 2016.
View Article : Google Scholar : PubMed/NCBI
|
